TY - JOUR
T1 - What to say and how to say it
T2 - Effective communication for cardiovascular disease prevention
AU - Navar, Ann Marie
AU - Stone, Neil J.
AU - Martin, Seth S.
N1 - Publisher Copyright:
© 2016 Wolters Kluwer Health, Inc.
PY - 2016/9/1
Y1 - 2016/9/1
N2 - Purpose of review Current guidelines for cholesterol treatment emphasize the importance of engaging patients in a risk-benefit discussion prior to initiating statin therapy. Recent findings Although current risk prediction algorithms are well defined, there is less data on how to communicate with patients about cardiovascular disease risk, benefits of treatment, and possible adverse effects. Summary We propose a four-part model for effective shared decision-making: 1) Assessing patient priorities, perceived risk, and prior experience with cardiovascular risk reduction; 2) Arriving at a recommendation for therapy based on the patient's risk of disease, guideline recommendations, new clinical trial data, and patient preferences; 3) Communicating this recommendation along with risks, benefits, and alternatives to therapy following best practices for discussing numeric risk; and 4) Arriving at a shared decision with the patient with ongoing reassessment as risk factors and patient priorities change.
AB - Purpose of review Current guidelines for cholesterol treatment emphasize the importance of engaging patients in a risk-benefit discussion prior to initiating statin therapy. Recent findings Although current risk prediction algorithms are well defined, there is less data on how to communicate with patients about cardiovascular disease risk, benefits of treatment, and possible adverse effects. Summary We propose a four-part model for effective shared decision-making: 1) Assessing patient priorities, perceived risk, and prior experience with cardiovascular risk reduction; 2) Arriving at a recommendation for therapy based on the patient's risk of disease, guideline recommendations, new clinical trial data, and patient preferences; 3) Communicating this recommendation along with risks, benefits, and alternatives to therapy following best practices for discussing numeric risk; and 4) Arriving at a shared decision with the patient with ongoing reassessment as risk factors and patient priorities change.
KW - prevention
KW - risk communication
KW - shared decision-making
UR - http://www.scopus.com/inward/record.url?scp=84978681139&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84978681139&partnerID=8YFLogxK
U2 - 10.1097/HCO.0000000000000322
DO - 10.1097/HCO.0000000000000322
M3 - Review article
C2 - 27428113
AN - SCOPUS:84978681139
SN - 0268-4705
VL - 31
SP - 537
EP - 544
JO - Current Opinion in Cardiology
JF - Current Opinion in Cardiology
IS - 5
ER -